Showing 771-780 of 1820 results for "".
Pearls for Choosing and Initiating Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0309_18-php/22872/Members of the psoriasis panel at the 2009 South Beach Symposium last month offered insights on patient care.Look to the EAST: Shared Decision Making in the Era of New Therapies
https://practicaldermatology.com/topics/atopic-dermatitis/look-to-the-east-shared-decision-making-in-the-era-of-new-therapies/23372/Assessing Efficacy, Accessibility, Safety, and Tolerability is the key to a meaningful dialogue with patients.A Practical Approach to Disorders of Hypopigmentation
https://practicaldermatology.com/topics/pigmentary-disorders/a-practical-approach-to-disorders-of-hypopigmentation/67254/Hypopigmentation comprises a broad spectrum of disorders characterized by decreased pigmentation in the presence of intact but functionally impaired melanocytes.New Products and Devices
https://practicaldermatology.com/columns/new-products/new-products-and-devices/20567/New products and pharmacologic developmentsDermWireTV: Derm Salaries Down, Allergan Eyes Soliton, Emsculpt Week
https://practicaldermatology.com/topics/practice-management/dermwiretv-derm-salaries-down-allergan-eyes-soliton-emsculpt-week/19941/Just under half of all physicians in the US are employed in physician-owned medical practices, new data from the American Medical Association show. Medscape’s annual Physician Compensation Report reveals that physicians overall saw a reduction in income due to the COVID-19 pandemic; income for dermDermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)Purified Botulinum Toxin Type A Complex for Bilateral Palmar Hyperhidrosis: A Case Report and Literature Review
https://practicaldermatology.com/programs/practical-dermatology/purified-botulinum-toxin-type-a-complex-for-bilateral-palmar-hyperhidrosis-a-case-report-literature-review/23984/A 40-year-old Caucasian woman presented to the clinic for persistent sweating of the bilateral hands, including the volar surface of the hand extending to the respective surfaces of the digits beginning approximately 20 years ago. Unsuccessful prior therapies include antiperspirants, the use of an iAssessing Dystrophic Nails: Finding the Cause
https://practicaldermatology.com/topics/general-topics/assessing-dystrophic-nails-finding-the-cause/21397/A podiatrist offers a unique perspective on the causes of dystrophic toenails.New Products and Pharmacologic Advancements
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-advancements/21663/Hitting the Reset Button on Dermatology Practices
https://practicaldermatology.com/topics/practice-management/hitting-the-reset-button-on-dermatology-practices/23312/Instead of just restarting our practices after COVID-19, why don’t we hit reset? Here’s how.